Investor relations
A disciplined path from pipeline to patients
A focused, late-stage pipeline, a clear registration strategy and a team with a proven track record — here's what we're building for shareholders.
Stock information
Zentia Therapeutics (NASDAQ: ZNTA)
Market data shown as of last market close. Placeholder values for demonstration.
Share price
$0.00
▲ +1.8% today
Market cap
$2.1B
▲ 52-week high
Volume
1.4M
Avg 30-day
52-week range
$18.20–39.75
High / low
Investor presentation
The Zentia story in one deck
Corporate presentation
Corporate Presentation — Q3 2026
The science behind Zent-001, our late-stage clinical data, the market opportunity and our path to registration.
Download the latest presentation and quarterly update.
Governance
Corporate governance
Independent oversight and transparent practices.
Board of DirectorsIndependent, majority-led oversight
Audit CommitteeFinancial reporting & controls
Compensation CommitteeExecutive compensation oversight
Nominating & Governance CommitteeBoard composition & ethics
SEC filings
Filings & documents
Resources
IR resources & alerts
Subscribe to email alerts and access frequently used investor tools.